Skip to main content

Peer Review reports

From: Double-blind placebo-controlled randomized clinical trial to assess the efficacy of montelukast in mild to moderate respiratory symptoms of patients with long COVID: E-SPERANZA COVID Project study protocol

Original Submission
24 Sep 2021 Submitted Original manuscript
27 Oct 2021 Reviewed Reviewer Report - Kirsty Loudon
9 Dec 2021 Author responded Author comments - Francisco Mera-Cordero
Resubmission - Version 2
9 Dec 2021 Submitted Manuscript version 2
16 Dec 2021 Author responded Author comments - Francisco Mera-Cordero
Resubmission - Version 3
16 Dec 2021 Submitted Manuscript version 3
Publishing
17 Dec 2021 Editorially accepted
6 Jan 2022 Article published 10.1186/s13063-021-05951-w

You can find further information about peer review here.

Back to article page